Noura Abul-Husn

Noura Abul-Husn is an Associate Professor at the Icahn School of Medicine at Mount Sinai and Vice President of Genomic Health at 23andMe. Her work focuses on translational genomics, integrating genomic data into clinical practice with a particular emphasis on liver disease genetics, polygenic risk assessment, and health equity. She leads initiatives like the NYCKidSeq study, exploring genomic result disclosure for pediatric patients using telehealth and digital tools like GUÍA.

Education: MD from Icahn School of Medicine at Mount Sinai (2009), Master of Science in Health (MSH '14).

Research Interests: Her studies address genetic variants linked to liver disease (e.g., HSD17B13, PNPLA3), hereditary transthyretin amyloidosis (TTR V142I), and implementation science for genomic medicine. She advocates for equitable genomic screening across diverse populations and has contributed to clinical guidelines for secondary finding reporting in genomic sequencing.

Articles Trends: Recent work emphasizes polygenic risk score validation, telehealth integration in genetic counseling, and molecular diagnostic yield of genome sequencing. Key themes include ancestry-specific genomics and clinical utility of genomic data in pediatric and adult populations.

Advising & Grants: Leads large-scale genomic screening projects (e.g., eMERGE, NYCKidSeq) and collaborates on pharmacogenomics initiatives. Her team develops tools for genomic result communication in multilingual families.

Labs/Teams: Directs genomic health initiatives at 23andMe and maintains an academic lab focused on translational genomic medicine at Mount Sinai.